Increasing the accumulation of modular nanotransporters in mouse tumors by attaching polyethylene glycol to these nanotransporters with the possibility of its release into the tumors

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Previously, polypeptide constructs – modular nanotransporters (MNT) – were created to deliver biologically active molecules into the nuclei of melanoma cells. In the present work, polyethylene glycol (PEG) molecules were attached to them at the N-terminal cysteine, both with the possibility of their subsequent cleavage at the hydrolysis site of tumor-specific proteases, and without this site (non-detachable PEG). All MNT variants labeled with the radioisotope 111In were administered to mice with inoculated Cloudman S91 melanoma. The kinetics of radioactivity distribution in the mouse body was studied using single-photon emission computed tomography. Analysis of the obtained data using a compartmental mathematical model allowed us to establish that the attachment of PEG to MNT increased its lifetime in the blood and significantly increased its accumulation in the tumor. Addition of a PEG detachment site by tumor-specific protease led to a strong retention of this MNT in the tumor. The data obtained can serve as a basis for the creation of new effective antitumor drugs.

About the authors

Y. V. Khramtsov

Institute of Gene Biology, RAS

Moscow, Russian Federation

A. V. Ulasov

Institute of Gene Biology, RAS

Moscow, Russian Federation

T. A. Slastnikova

Institute of Gene Biology, RAS

Moscow, Russian Federation

G. P. Georgiev

Institute of Gene Biology, RAS

Moscow, Russian Federation

A. S. Sobolev

Institute of Gene Biology, RAS; Lomonosov Moscow State University

Email: alsobolev@yandex.ru
Moscow, Russian Federation; Moscow, Russian Federation

References

  1. Slastnikova T.A., Rosenkranz A.A., Gulak P.V., et al. // Int. J. Nanomed. 2012. V. 7. P. 467–482.
  2. Aloia T.A., Fahy B.N. // Expert Rev. Anticancer Ther. 2010. V. 10. P. 521–527.
  3. Nikitin N.P., Zelepukin I.V., Shipunova V.O., et al. // Nat. Biomed. Eng. 2020. V. 4(7). P. 717–731.
  4. An Q., Lei Y., Jia N., et al. // Biomol. Eng. 2007. V. 24. P. 643–649.
  5. Pfister D., Morbidelli M. // J. Contr. Release. 2014. V. 180. P. 134–149.
  6. Khramtsov Y.V., Ulasov A.V., Rosenkranz A.A., et al. // Dokl. Biochem. Biophys. 2018. V 478. P. 55–57.
  7. Desnoyers L.R., Vasiljeva O., Richardson J.H., et al. // Sci. Transl. Med. 2013. V. 5(207). 207ra144.
  8. Siegrist W., Solca F., Stutz S., et al. // Cancer Res. 1989. V. 49. P. 6352–6358.
  9. Thurber G.M., Dane W.K. // J. Theor. Biol. 2012. V. 314. P. 57–68.
  10. Al-Ejeh F., Croucher D., Ranson M. // Exp. Cell Res. 2004. V. 297. P. 259–271.
  11. Sinharay S., Howison C.M., Baker A.F., et al. // NMR Biomed. 2017. V. 30(7).

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Russian Academy of Sciences

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).